Cambridge biotech companies burn through cash for years before reaching revenue. Runway calculations here are existential. Investors expect CFO-level reporting.
A fractional Finance Director provides senior financial leadership to your business on a part-time basis. You get the strategic expertise of an experienced FD without the full-time salary commitment.
In Cambridge, businesses typically pay £150,000+ for a full-time Finance Director. A fractional FD gives you access to the same level of expertise from £2,000 per month.
Cambridge is Europe's leading life sciences cluster and a global AI hub. University spinouts have created one of the world's densest concentrations of deeptech companies. High operating costs reflect premium talent and facilities, but access to world-class research and investment makes it essential for certain sectors.
Average office rent
£45-55/sq ft (Science Park)
Life sciences companies
500+ in cluster
Annual VC investment
£3bn+ in region
University spinouts
30+ annually
Every market has unique financial challenges. Here's what Cambridge businesses face and how Finley helps.
Runway modelling with clinical milestone integration, showing investors exactly when capital is needed.
Unit economics modelling and scenario planning for pivot-to-revenue timing decisions.
Grant wind-down management and investor-ready financial reporting for funding transitions.
Revenue recognition for licensing deals and milestone-based income from pharma partnerships.
Cambridge has one of the world's most sophisticated life sciences funding ecosystems. From university grants through to Series D and beyond, every stage is well-served. Specialist biotech and AI investors are headquartered locally, with strong syndication networks.
Understanding UK tax incentives and regulatory requirements is crucial for financial planning.
Biotech companies face strict financial controls for clinical trials. Audit trails essential.
Life sciences R&D qualifies for enhanced relief. Proper cost categorisation critical for claims.
Cambridge IP-rich companies can benefit from lower tax rates. Financial structure matters.
Deep experience with Cambridge biotech companies from spinout to exit
Track record with AI companies navigating the research-to-revenue transition
Understanding of life sciences investor expectations and reporting requirements
Benchmarks include Cambridge-specific cost and burn rate data for peer comparison
Other fractional Finance Director providers in Cambridge include Peters Elworthy Moore, Price Bailey, Ensors. Here is what makes Finley different:
We use AI to process your transactions and surface insights. No waiting for monthly reports - see your cash position in real-time.
Flat monthly fee based on your needs. No hourly billing surprises. No scope creep charges.
Access your financial dashboard anytime. Chat with Finley AI for instant answers. Human support when you need strategic guidance.
See where your cash will be in 30, 60, 90 days. No spreadsheet guesswork.
AI spots unusual spending patterns before they become problems.
Clear reports you can share with investors, board members, or your bank.
Know exactly how long your current cash will last at current burn rate.
Automatic categorisation shows where every £ goes.
Human experts available for fundraising, M&A, and growth planning.
Upload your bank statement and get your first cash flow analysis free. No credit card required.
Questions about our Cambridge services?
Get in touch with our team